Myelomonocytic leukemia

Leah SherwoodMyelodysplastic Syndromes | November 15, 2022
Study finds BM CH was present in nearly two-thirds of BPDCN patients and particularly prevalent in elderly patients.
Kerri FitzgeraldAcute Myeloid Leukemia | February 2, 2023
The FDA and Finnish Medicines Agency cleared the investigational new drug application for bexmarilimab.
Advertisement
Advertisement
Advertisement
Advertisement